For example, recent data suggests that aberrant activation of MAPK pathways may play an important role in diverting the TGF-β response towards a pro-oncogenic outcome, and that TGF-β and activated Ras may cooperate to promote invasive, metastatic disease (Park et al, 2000). The gene discussed is TGFB1; the disease is metastatic neoplasm.